Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 12:24 pm Sale |
2020-12-31 | 13G | Chembio Diagnostics, Inc. CEMI |
Laurence W. Lytton | 0 0.000% |
-1,010,718 (Position Closed) |
Filing History |
| 2021-02-16 11:46 am Purchase |
2020-12-31 | 13G | VERTEX ENERGY INC VTNRQ |
Laurence W. Lytton | 4,093,561 9.000% |
1,374,473 (+50.55%) |
Filing History |
| 2021-02-16 11:43 am Purchase |
2020-12-31 | 13G | Ra Medical Systems, Inc. RMED |
Laurence W. Lytton | 4,819 7.700% |
4,819 (New Position) |
Filing History |
| 2021-02-16 11:39 am Sale |
2020-12-31 | 13G | LiqTech International, Inc. LIQT |
Laurence W. Lytton | 240,273 8.700% |
-31,963 (-11.74%) |
Filing History |
| 2021-02-16 11:37 am Purchase |
2020-12-31 | 13G | HTG Molecular Diagnostics, Inc. HTGM |
Laurence W. Lytton | 5,812,944 9.990% |
5,812,944 (New Position) |
Filing History |
| 2021-02-16 11:34 am Purchase |
2020-12-31 | 13G | Giga-tronics Incorporated GIGA |
Laurence W. Lytton | 247,700 9.400% |
1,900 (+0.77%) |
Filing History |
| 2021-02-16 11:32 am Sale |
2020-12-31 | 13G | EMCORE Corporation EMKR |
Laurence W. Lytton | 171,830 5.800% |
-104,058 (-37.72%) |
Filing History |
| 2021-02-16 11:30 am Sale |
2020-12-31 | 13G | Duos Technologies Group, Inc. DUOT |
Laurence W. Lytton | 215,700 6.100% |
-67,300 (-23.78%) |
Filing History |
| 2021-02-16 11:26 am Purchase |
2020-12-31 | 13G | Cellectar Biosciences, Inc. CLRB |
Laurence W. Lytton | 474,400 9.990% |
234,138 (+97.45%) |
Filing History |
| 2021-02-16 11:22 am Sale |
2020-12-31 | 13G | Apollo Endosurgery, Inc. APEN |
Laurence W. Lytton | 2,648,150 9.990% |
-17,782 (-0.67%) |
Filing History |
| 2021-01-04 12:35 pm Purchase |
2020-12-22 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS |
Laurence W. Lytton | 1,598,519 8.800% |
1,598,519 (New Position) |
Filing History |
| 2020-06-12 4:09 pm Purchase |
2020-06-05 | 13G | Cellectar Biosciences, Inc. CLRB |
Laurence W. Lytton | 240,262 9.990% |
240,262 (New Position) |
Filing History |
| 2020-05-29 1:44 pm Purchase |
2020-05-21 | 13G | LiqTech International, Inc. LIQT |
Laurence W. Lytton | 272,236 9.800% |
272,236 (New Position) |
Filing History |
| 2020-05-29 1:36 pm Purchase |
2020-05-22 | 13G | Ra Medical Systems, Inc. RMED |
Laurence W. Lytton | 2,970 9.990% |
2,734 (+1155.95%) |
Filing History |
| 2020-05-29 10:17 am Sale |
2020-05-20 | 13G | Allena Pharmaceuticals, Inc. ALNAQ |
Laurence W. Lytton | 0 0.000% |
-37,205,000 (Position Closed) |
Filing History |